BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

986 related articles for article (PubMed ID: 8092216)

  • 1. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract?
    Mehanna MT; Rizk MA; Ramadan M; Schachter J
    Am J Obstet Gynecol; 1994 Sep; 171(3):691-3. PubMed ID: 8092216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residues of pelvic inflammatory disease in intrauterine device users: a result of the intrauterine device or Chlamydia trachomatis infection?
    Guderian AM; Trobough GE
    Am J Obstet Gynecol; 1986 Mar; 154(3):497-503. PubMed ID: 3513579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Past use of an intrauterine device and risk of tubal pregnancy.
    Rossing MA; Daling JR; Weiss NS; Voigt LF; Stergachis AS; Wang SP; Grayston JT
    Epidemiology; 1993 May; 4(3):245-51. PubMed ID: 8512988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydial serology among patients with tubal factor infertility and ectopic pregnancy in Alexandria, Egypt.
    Mehanna MT; Rizk MA; Eweiss NY; Ramadan M; Zaki SA; Sadek A; Chow JM; Schachter J
    Sex Transm Dis; 1995; 22(5):317-21. PubMed ID: 7502187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
    Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
    Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current use of an intrauterine device and risk of tubal pregnancy.
    Rossing MA; Daling JR; Voigt LF; Stergachis AS; Weiss NS
    Epidemiology; 1993 May; 4(3):252-8. PubMed ID: 8512989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New studies link IUDs, infertility; say copper devices safer.
    Contracept Technol Update; 1985 Jun; 6(6):81-3. PubMed ID: 12313655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of intrauterine contraceptive devices, pelvic inflammatory disease, and Chlamydia trachomatis infection.
    Edelman DA
    Am J Obstet Gynecol; 1988 Apr; 158(4):956-9. PubMed ID: 3284365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of prior pelvic inflammatory disease and its relationship to Chlamydia trachomatis antibody and intrauterine contraceptive device use in infertile women.
    Gump DW; Gibson M; Ashikaga T
    Am J Obstet Gynecol; 1983 May; 146(2):153-9. PubMed ID: 6846431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation.
    Faundes A; Alvarez F; Brache V; Tejada AS
    Int J Gynaecol Obstet; 1988 Jun; 26(3):429-33. PubMed ID: 2900174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of intrauterine devices. II. Intrauterine devices and pelvic inflammatory disease and ectopic pregnancy.
    Malhotra N; Chaudhury RR
    Obstet Gynecol Surv; 1982 Jan; 37(1):1-8. PubMed ID: 7054735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of serum steroid hormones in intrauterine contraceptive device users.
    Fahmy K; el-Gazar A; Eisa I; Ghonaim M; Saad S; Afifi A
    Gynecol Endocrinol; 1991 Mar; 5(1):1-5. PubMed ID: 1897380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of adding copper onto Lippes Loop IUDs: results from a ten-year study in Yugoslavia.
    Randic L; Haller H; Perovic M; Farr G
    Contraception; 1991 Mar; 43(3):229-39. PubMed ID: 2036794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IgG and IgA antibodies to Chlamydia in ectopic pregnancies.
    Chaim W; Sarov B; Sarov I; Piura B; Cohen A; Insler V
    Contraception; 1989 Jul; 40(1):59-71. PubMed ID: 2673659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary tubal infertility in relation to the use of an intrauterine device.
    Daling JR; Weiss NS; Metch BJ; Chow WH; Soderstrom RM; Moore DE; Spadoni LR; Stadel BV
    N Engl J Med; 1985 Apr; 312(15):937-41. PubMed ID: 3974683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubal infertility and the intrauterine device.
    Cramer DW; Schiff I; Schoenbaum SC; Gibson M; Belisle S; Albrecht B; Stillman RJ; Berger MJ; Wilson E; Stadel BV
    N Engl J Med; 1985 Apr; 312(15):941-7. PubMed ID: 3974684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contraception and tubal sterility of infective origin].
    Gayer ML; Henry-Suchet J
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(2):155-64. PubMed ID: 2324437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users.
    Makhlouf H; Abou-gabal A; El-hefnawi N; Khalifa A
    Popul Sci; 1988; (8):19-29. PubMed ID: 12343623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.